Purple Biotec-L(IL:PPBT.L)
ILAÂ 1.000.00 (0.00%)
IL:PPBT.L
Purple Biotec-L financials statements
ILAÂ 1.00
At close:0.00 (0.00%)
Want to see IL:PPBT.L full AI Analyst Report?
Purple Biotec-L (PPBT.L) Ratios
1 Followers
Purple Biotec-L Ratios
IL:PPBT.L's free cash flow for Q2 2026 was $-2.51M. For the 2026 fiscal year, IL:PPBT.L's free cash flow was increased by $0.00 and operating cash flow was $-2.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.27 | 2.23 | 2.20 | 4.71 | 11.41 |
| Quick Ratio | 1.27 | 2.23 | 2.20 | 4.71 | 11.41 |
| Cash Ratio | 1.12 | 1.86 | 2.02 | 2.13 | 2.56 |
| Solvency Ratio | -3.31 | -1.71 | 0.00 | -2.85 | -3.57 |
| Operating Cash Flow Ratio | -0.77 | -3.60 | -2.77 | -2.37 | -3.55 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.95M | $ 4.78M | $ 5.78M | $ 25.73M | $ 43.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.81 | 1.13 | 1.30 | 1.16 | 1.08 |
| Debt Service Coverage Ratio | -24.69 | -172.00 | -354.91 | -320.78 | -82.62 |
| Interest Coverage Ratio | -25.83 | -268.41 | -397.70 | -337.36 | -84.59 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.32 | 1.02 | 0.71 | 0.68 | 0.58 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | -0.10% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | -10173.95% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | -10150.46% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | -11374.13% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | -10202.55% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | -10.15% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -10202.55% | 0.00% | 0.00% |
| Net Income Per EBT | 99.60% | 99.46% | 0.10% | 99.58% | 103.13% |
| EBT Per EBIT | 96.48% | 66.14% | 89.70% | 96.27% | 99.40% |
| Return on Assets (ROA) | -150.13% | -19.55% | -0.04% | -39.67% | -26.19% |
| Return on Equity (ROE) | -271.57% | -22.03% | -0.06% | -46.19% | -28.36% |
| Return on Capital Employed (ROCE) | -279.58% | -33.30% | -60.00% | -47.52% | -27.19% |
| Return on Invested Capital (ROIC) | -272.81% | -33.11% | -59.70% | -47.33% | -27.11% |
| Return on Tangible Assets | -258.33% | -78.73% | -0.12% | -63.85% | -36.98% |
| Earnings Yield | -729.76% | -68.94% | -0.09% | -80.90% | -26.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.11 | 0.04 | 0.06 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.42 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | -3439.08 | -8565.73 | -6577.45 | -6484833.33 | -9775363.64 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 3439.08 | 8565.73 | 6577.45 | 6484833.33 | 9775363.64 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.08 | -0.09 | -0.08 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.08 | -0.09 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | -1831.23 | 0.00 | -6641.67 | -73.40 | -131.05 |
| Capital Expenditure Coverage Ratio | -1831.23 | 0.00 | -6641.67 | -73.40 | -131.05 |
| Operating Cash Flow Coverage Ratio | -24.36 | -78.51 | -56.77 | -32.50 | -20.12 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -101.76 | 0.00 | 0.00 |
| Free Cash Flow Yield | -164.54% | -136.80% | -88.62% | -63.33% | -22.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.13 | -0.92 | -1131.19 | -1.24 | -3.72 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 114.85 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.37 | 0.32 | 0.66 | 0.57 | 1.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.61 | -0.73 | -1.13 | -1.58 | -4.51 |
| Price-to-Operating Cash Flow Ratio | -0.61 | -0.73 | -1.13 | -1.60 | -4.54 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.00 | 40.72 | -0.19 | 0.10 |
| Enterprise Value Multiple | 0.19 | -0.47 | -0.42 | -0.57 | -3.33 |
| Enterprise Value | -4.86M | 3.28M | 8.35M | 12.27M | 58.31M |
| EV to EBITDA | 0.19 | -0.47 | -0.42 | -0.57 | -3.33 |
| EV to Sales | 0.00 | 0.00 | 42.65 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.82 | -0.23 | -0.42 | -0.72 | -3.84 |
| EV to Operating Cash Flow | 0.82 | -0.23 | -0.42 | -0.73 | -3.87 |
| Tangible Book Value Per Share | 0.00 | 0.01 | 0.03 | 0.14 | 0.25 |
| Shareholders’ Equity Per Share | 0.01 | 0.06 | 0.14 | 0.25 | 0.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.01 | -0.00 | -0.12 | -0.10 |
| Tax Burden | 1.00 | 0.99 | 0.00 | 1.00 | 1.03 |
| Interest Burden | 1.00 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 87.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 24.74 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 9.58 | 0.00 | 0.00 |
| Income Quality | 0.22 | 1.97 | 1.00 | 0.77 | 0.85 |
Currency in USD
